Company intelligence / Profile preview

Jobevne

Copenhagen, Denmark

Ownership: Private
Development stage: Other

Overview

Jobevne is a pre-clinical stage biotechnology company focused on developing novel therapeutics for difficult-to-treat cancers, with a primary emphasis on glioblastoma. The company's lead research centers on targeting the cystine/glutamate transporter (xCT) to disrupt the metabolic pathways that allow tumor cells to resist oxidative stress and conventional therapies. By inhibiting this transporter, Jobevne aims to induce ferroptosis and enhance the efficacy of standard-of-care treatments. The company is currently advancing its lead candidates through lead optimization and early proof-of-concept studies.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Jobevne.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jobevne.

Explore the full profile